Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.

Government College University Faisalabad

Status: Completed

Conditions: Covid19

Treatments: Other: Physical Exercises

Study type: Interventional

Funder types: Other

Identifiers

NCT04445376

313

Details and patient eligibility

About

In some patients, lung function declined by about 20 to 30% after recovery. Computer tomography of COVID-19 patients revealed a ground glass opacity in both lungs. We will measure the Cardiorespiratory fitness according to American College of Sports medicine guidline and provide physiotherapy exercise to the patients to measure the improvement.

Full description

In December 2019, the first reports emerged of a novel severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) in Wuhan, China. The virus, which causes atypical pneumonia progressing to acute lung injury and acute respiratory distress syndrome (ARDS) in some individuals, was named COVID-19. The burden of fibrotic lung disease following SARS-CoV-2 infection is likely to be high; therefore, given the scale of the pandemic, the global burden of fibrotic lung disease will probably increase considerably. The aim of this study is to check the cardiorespiratory fitness level and the effect of Physical therapy intervention to improve the Cardiorespiratory fitness level in patients recovered from COVID-19. Quality of life has also been affected due to COVID19 due to decreased Cardiorespiratory fitness level, and this study also aims to improve the quality of life of people recovered from COVID19.

Enrollment: 20 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Recovered from COVID 19 disease (PCR report).
• Sub-normal performance as compared to normative data.
• Do not have any Respiratory Problem.
• Consent to participate in the study.
• Able to understand and perform the exercise.
• Age from 18 to 75.
• Dyspnea due to COVID19.
• Modified Borg Dyspnea Scale score at least 2 but less than 7.

Exclusion criteria

• Not suffered from COVID 19.
• Respiratory Problem.
• Resting Blood Pressure greater than 160/100 instead of taking medicine
• Greater than 1-month post COVID19 Recovery.
• Cardiorespiratory comorbidities which limit participation in exercise.
• Any Musculoskeletal problem which limit participation in Training.
• Other cardiovascular morbidity which would limit exercise tolerance (heart failure, abnormal blood pressure responses or ST-segment depression > 2mm, symptomatic aortic stenosis, complex arrhythmias).
• Unstable angina
• Orthostatic blood pressure decrease of >20 mmHg with symptoms
• Hypertropic cardiomyopathy

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

20 participants in 2 patient groups

Intervention Group (Ventilatory)

Experimental group

Description:

Breathing Exercise and Aerobic Training will be provided to all the patients.The training session will be given 3 days a week.

Treatment:

Other: Physical Exercises

Intervention (Non ventilatory)

Experimental group

Description:

Breathing Exercise and Aerobic Training will be provided to all the patients.The training session will be given 3 days a week.

Treatment:

Other: Physical Exercises